Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.
If you're having trouble pronouncing the name of the newly funded SGLT2 inhibitor for type 2 diabetes, you're not the only one! Watch our video guide to learn how to pronounce empagliflozin.
A new study from the University of Auckland examined ethnic variation in the quality use of medicines between Māori and non-Māori older adult populations. Simon Maude from New Zealand Doctor Rata Aotearoa spoke to the study's lead author Joanna Hikaka and investigated the impact of this research.
Inequities exist in all aspects of diabetes care. In this article, Alesha Smith outlines some examples, proposes some actions, and explains where the new medicines fit in.
This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 0.5 CME credits for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes.
Late last year, PHARMAC announced the SGLT2 inhibitor empagliflozin (Jardiance®) and empagliflozin with metformin (Jardiamet®) will be funded for the treatment of type 2 diabetes under Special Authority.
Find out all you need to know about the Special Authority criteria.
In this webinar, Dr Alesha Smith discusses the development of He Ako Hiringa and presents our new interactive data tool, EPiC. You can watch this webinar here or in ELearning.
In this webinar, Dr Rinki Murphy discusses the issue of inequity in diabetes care. You can watch this webinar here or in ELearning.
In this webinar, Sandy Bhawan and Dr Emily Gill discuss how to improve medicine access equity in primary care. You can watch this webinar here or in ELearning.
The call for equity in healthcare is not new but it is louder than it has ever been before. This article shares the experiences of primary care clinicians around the country as they work to improve medicine access equity for patients. This article is part of a course, which is accredited by PSNZ for Group 2 points for pharmacists and endorsed by CNA(NZ) for 1.5 professional development hours for nurses. It is also suitable for professional development for general practitioners.
Do you need help improving your understanding of medicine access equity issues? In this video you will hear from a number of primary healthcare professionals who are working to improve equity outcomes in the services they provide to patients